Coherus Oncology Inc.

CHRS | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.33

-$0.04 (-2.92%)

Sep 22, 2026, 11:27 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	168.02M	28.51M	-237.89M	-291.75M	-287.1M	132.24M
Depreciation & Amortization	3.92M	5.28M	3.79M	3.7M	3.45M	2.89M
Stock-Based Compensation	16.97M	27.8M	43.11M	50.74M	51.36M	38.16M
Other Working Capital	-62.74M	-57.57M	136.83M	-40.41M	13.68M	28.75M
Other Non-Cash Items	-321.59M	-137.92M	52.93M	75.45M	143.05M	15.5M
Deferred Income Tax	n/a	n/a	n/a	n/a	9.44M	n/a
Change in Working Capital	-5.84M	55.89M	-36.83M	-79.26M	42.36M	-34.65M
Operating Cash Flow	-138.51M	-20.44M	-174.88M	-241.12M	-37.43M	154.15M
Capital Expenditures	n/a	n/a	-286K	-2.04M	-1.29M	-7.23M
Cash Acquisitions	n/a	n/a	845K	n/a	1.29M	n/a
Purchase of Investments	-103.84M	n/a	-19.51M	-127.38M	-182.49M	-273.85M
Sales Maturities Of Investments	21.46M	14.89M	157.64M	n/a	181.36M	274M
Other Investing Acitivies	457.46M	215.43M	5.95M	-37.43M	-137.29M	-7.33M
Investing Cash Flow	375.09M	230.32M	144.64M	-166.85M	-138.41M	-14.4M
Debt Repayment	-233.19M	-223.41M	n/a	49.93M	-672K	222.16M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-48.77M	34.98M	-4.62M	-1.96M	54.3M	1.79M
Financial Cash Flow	-273.71M	-186.97M	69.6M	54.33M	51.88M	223.95M
Net Cash Flow	-37.13M	22.91M	39.34M	-353.65M	-123.96M	363.69M
Free Cash Flow	-138.51M	-20.44M	-175.17M	-243.16M	-38.72M	146.91M
Adj. Free Cash Flow	-155.48M	-48.24M	-218.28M	-293.9M	-90.09M	108.75M
Maintenance CapEx	n/a	n/a	n/a	-2.04M	-1.29M	n/a
Growth CapEx	n/a	n/a	-286K	n/a	n/a	-7.23M
Owner Earnings	-138.51M	-20.44M	-174.88M	-243.16M	-38.72M	154.15M